{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:51:59Z","timestamp":1790596319123,"version":"4.1.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    The integration of multiple virtual screening strategies facilitates the balance of computational efficiency and prediction accuracy. In this study, we constructed an efficient and reliable \u201cmulti-stage virtual screening-in vitro biological validation\u201d system to identify potential inhibitors targeting extracellular signal-regulated protein kinase 2 (ERK2). Firstly, we rapidly obtained 10 candidate ERK2 inhibitors with desirable pharmacokinetic characteristics from thousands of named natural products in ZINC database based on machine learning classification models and ADME\/T prediction. The structure-based molecular docking approach was then used to obtain four further hits with lower binding free energy compared to the positive control molecule Magnolipin. Subsequently, the two compounds were purchased for\n                    <jats:italic>in vitro<\/jats:italic>\n                    biological validation considering commercial availability and economic cost, and the results showed that Dodoviscin A exhibited acceptable inhibitory activity on ERK2 (IC\n                    <jats:sub>50<\/jats:sub>\n                    = 10.79\u00a0\u03bcm). Finally, the mechanism of action and binding stability of this natural product inhibitor were investigated by binding mode analysis and molecular dynamics simulation.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2022.1077550","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:02:50Z","timestamp":1668729770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification of potential extracellular signal-regulated protein kinase 2 inhibitors based on multiple virtual screening strategies"],"prefix":"10.3389","volume":"13","author":[{"given":"Ruoqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fninf.2014.00014","article-title":"Machine learning for neuroimaging with scikit-learn","volume":"8","author":"Abraham","year":"2014","journal-title":"Front. Neuroinform."},{"key":"B2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573409911309020006","article-title":"Evolutionary computation and QSAR research","volume":"9","author":"Aguiar-Pulido","year":"2013","journal-title":"Curr. Comput. Aided. Drug Des."},{"key":"B3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.molonc.2014.01.003","article-title":"Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma","volume":"8","author":"Carlino","year":"2014","journal-title":"Mol. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1016\/j.bmcl.2012.07.089","article-title":"A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/cb300610s","article-title":"Kinase drug discovery--what's next in the field?","volume":"8","author":"Cohen","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jfoodeng.2017.02.017","article-title":"Prediction of the level of astringency in persimmon using visible and near-infrared spectroscopy","volume":"204","author":"Cort\u00e9s","year":"2017","journal-title":"J. Food Eng."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nchembio.1881","article-title":"Curation of chemogenomics data","volume":"11","author":"Fourches","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrclinonc.2015.213","article-title":"Kinase inhibitors and monoclonal antibodies in oncology: Clinical implications","volume":"13","author":"Gharwan","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jmgm.2006.06.005","article-title":"Statistical external validation and consensus modeling: A QSPR case study for koc prediction","volume":"25","author":"Gramatica","year":"2007","journal-title":"J. Mol. Graph. Model."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: Machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"key":"B14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1208\/s12248-018-0210-0","article-title":"Deep learning for drug design: An artificial intelligence paradigm for drug discovery in the big data era","volume":"20","author":"Jing","year":"2018","journal-title":"AAPS J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1021\/jm100087s","article-title":"Intramolecular hydrogen bonding in medicinal chemistry","volume":"53","author":"Kuhn","year":"2010","journal-title":"J. Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"B17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12885-015-1580-7","article-title":"Magnolin inhibits cell migration and invasion by targeting the ERKs\/RSK2 signaling pathway","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.drudis.2019.03.003","article-title":"Machine learning on adverse drug reactions for pharmacovigilance","volume":"24","author":"Lee","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1128\/MCB.00800-07","article-title":"Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels","volume":"28","author":"Lefloch","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1109\/TNN.2006.873281","article-title":"A geometric approach to support vector machine (SVM) classification","volume":"17","author":"Mavroforakis","year":"2006","journal-title":"IEEE Trans. Neural Netw."},{"key":"B21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1432-1033.1995.317_c.x","article-title":"Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2","volume":"234","author":"Meggio","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/1061186X.2019.1648477","article-title":"Development of ERK1\/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations","volume":"28","author":"Miao","year":"2020","journal-title":"J. Drug Target."},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbrc.2005.08.082","article-title":"Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex","volume":"336","author":"Ohori","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-09-3064","article-title":"Targeting the mitogen-activated protein kinase pathway: Physiological feedback and drug response","volume":"16","author":"Pratilas","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"Gromacs 4.5: A high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E2811","DOI":"10.3390\/molecules24152811","article-title":"Multi-level comparison of machine learning classifiers and their performance metrics","volume":"24","author":"Racz","year":"2019","journal-title":"Molecules"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1080\/07391102.2021.1905552","article-title":"Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1","volume":"40","author":"Raju","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B29","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1021\/acs.jmedchem.9b01989","article-title":"Drug research meets Network science: Where are we?","volume":"63","author":"Recanatini","year":"2020","journal-title":"J. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: An online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/17460441.2020.1776696","article-title":"The application of machine learning techniques to innovative antibacterial discovery and development","volume":"15","author":"Serafim","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","article-title":"Random forest: A classification and regression tool for compound classification and QSAR modeling","volume":"43","author":"Svetnik","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"L923","DOI":"10.1152\/ajplung.00023.2012","article-title":"Estrogen effects on human airway smooth muscle involve cAMP and protein kinase A","volume":"303","author":"Townsend","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"16771","DOI":"10.1038\/s41598-020-73681-1","article-title":"Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery","volume":"10","author":"Tsou","year":"2020","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.2174\/1568026619666181212102856","article-title":"Identification of drug binding sites and action mechanisms with molecular dynamics simulations","volume":"18","author":"Wang","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/jaoacint\/qsab002","article-title":"Nature identification of Chinese herbal medicine compounds based on molecular descriptors","volume":"104","author":"Wei","year":"2021","journal-title":"J. Aoac Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1055\/s-0032-1328649","article-title":"Dodoviscin a inhibits melanogenesis in mouse b16-f10 melanoma cells","volume":"79","author":"Yan","year":"2013","journal-title":"Planta Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/molecules27196249","article-title":"Discovery of novel c-jun N-terminal kinase 1 inhibitors from natural products: Integrating artificial intelligence with structure-based virtual screening and biological evaluation","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"107686","DOI":"10.1016\/j.pharmthera.2020.107686","article-title":"The strategies and techniques of drug discovery from natural products","volume":"216","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1077550\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:02:53Z","timestamp":1668729773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1077550\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":42,"alternative-id":["10.3389\/fphar.2022.1077550"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1077550","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"article-number":"1077550"}}